Viewing Study NCT07243366


Ignite Creation Date: 2025-12-24 @ 4:26 PM
Ignite Modification Date: 2025-12-25 @ 2:19 PM
Study NCT ID: NCT07243366
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-21
First Post: 2025-09-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis
Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-11-25
Start Date Type: ESTIMATED
Primary Completion Date: 2027-06-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-11-30
Completion Date Type: ESTIMATED
First Submit Date: 2025-09-09
First Submit QC Date: None
Study First Post Date: 2025-11-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-19
Last Update Post Date: 2025-11-21
Last Update Post Date Type: ESTIMATED